Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
about
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and TargetsNocturnal Pruritus: The Battle for a Peaceful Night's SleepHTR7 Mediates Serotonergic Acute and Chronic ItchTopical Tetracycline Improves MC903-induced Atopic Dermatitis in Mice through Inhibition of Inflammatory Cytokines and Thymic Stromal Lymphopoietin Expression.Pruritus: an overview. What drives people to scratch an itch?An Unexpected Role for TRPV4 in Serotonin-Mediated Itch.Addressing treatment challenges in atopic dermatitis with novel topical therapies.Atopic dermatitis phenotypes and the need for personalized medicine.The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis.Neuropathic symptoms of the ocular surface: dryness, pain, and itch.Acidosis counteracts itch tachyphylaxis to consecutive pruritogen exposure dependent on acid-sensing ion channel 3.Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients.Hypochlorous acid is antipruritic and anti-inflammatory in a mouse model of atopic dermatitis.Atopic Dermatitis in Animals and People: An Update and Comparative Review.Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine.Sensory TRP channels contribute differentially to skin inflammation and persistent itch.The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus.Burden of skin pain in atopic dermatitis.Management of Itch in Atopic Dermatitis.Neuro-immune interactions in allergic diseases: novel targets for therapeutics.Highly Selective Cleavage of Cytokines and Chemokines by the Human Mast Cell Chymase and Neutrophil Cathepsin G.Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway.Skin neurogenic inflammation.Antipruritic Effects of Botulinum Neurotoxins.
P2860
Q26746551-7366E3AE-B430-4665-B6F9-7999FA943E45Q26752133-61CA3ECF-B9C2-4F57-BF3D-877FC99E6A2AQ35951993-9C067E5B-3F8F-4069-8C0B-59A130F4A93EQ37011376-7DAFD8F7-38B7-47C9-A577-361EDB29066EQ37272308-C2FCC030-52A9-4925-9477-F5D9AF306997Q38544245-79B25D42-25B7-4EB9-881F-15CC6B098503Q38831401-E22870F0-222D-46FB-A13E-32AFE9FC39C6Q39352185-A15FA0B7-E200-4B6A-B7F1-893BF65E8814Q39402846-449561AE-52D3-4E3C-A09C-42A0D760C4CCQ40062999-FF2D4472-374F-4DAE-9A66-0541AF4032DEQ41168377-919E382B-06D7-4DC4-839D-0D80F6A5A9BEQ44792403-0D15BF09-811D-47B7-89FF-FB8BC001A136Q44876149-5DB8F666-985A-407E-8C18-C71AE5831CBDQ45601105-5D935133-E945-4B09-BBF0-61256C6D37FDQ46392264-4179C1DD-0A4C-4A52-90E4-B033A36B18BFQ47132169-522BBDF2-3308-483F-9AF3-0EBA227329D8Q47144191-3136070A-3E8F-4F39-9A4E-C7788D090135Q47548008-031546E4-F513-4C4E-8A68-7DAD51C86A49Q47650208-164A43E6-C96E-4FD9-A8AF-E87435809C49Q47800446-70F4C91E-722A-4351-AA1C-93A0333D4C4BQ48094970-B6E6A1C6-0D60-4081-9B52-4325823D6C96Q48205671-E4FAA377-C1B7-4AE6-9B3D-0F8EA61B407AQ54224167-711D35DD-7DBB-4159-9615-1E2528F9E57DQ55080639-EA67863C-C7E3-4051-B55A-A2DB97ED62BE
P2860
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
@en
type
label
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
@en
prefLabel
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
@en
P2093
P2860
P1476
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
@en
P2093
Gil Yosipovitch
Nicholas K Mollanazar
Peter K Smith
P2860
P2888
P304
P356
10.1007/S12016-015-8488-5
P577
2015-05-01T00:00:00Z
P5875
P6179
1000699649